Short term effects of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, tubular function and vasoactive hormones on healthy subjects.
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2012
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 16 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 04 Nov 2006 New trial record.